S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
Log in
NYSE:AGCB

Altimeter Growth Corp. 2 Competitors

$10.69
-0.31 (-2.82 %)
(As of 03/4/2021 04:15 PM ET)
Add
Compare
Today's Range
$10.25
Now: $10.69
$10.89
50-Day Range
$11.62
MA: $12.53
$13.93
52-Week Range
$10.25
Now: $10.69
$15.21
Volume602,434 shs
Average Volume535,651 shs
Market Capitalization$545.19 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Altimeter Growth Corp. 2 (NYSE:AGCB) Vs. CHPT, CMLF, AJAX, AJAX, TPGY, and BTWN

Should you be buying AGCB stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to Altimeter Growth Corp. 2, including Chargepoint (CHPT), CM Life Sciences (CMLF), Ajax I (AJAX), Ajax I (AJAX), TPG Pace Beneficial Finance (TPGY), and Bridgetown (BTWN).

Altimeter Growth Corp. 2 (NYSE:AGCB) and Chargepoint (NYSE:CHPT) are both small-cap unclassified companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Altimeter Growth Corp. 2 and Chargepoint, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Altimeter Growth Corp. 20000N/A
Chargepoint00103.00

Given Chargepoint's higher possible upside, analysts plainly believe Chargepoint is more favorable than Altimeter Growth Corp. 2.

Profitability

This table compares Altimeter Growth Corp. 2 and Chargepoint's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Altimeter Growth Corp. 2N/AN/AN/A
ChargepointN/AN/AN/A

Earnings and Valuation

This table compares Altimeter Growth Corp. 2 and Chargepoint's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Altimeter Growth Corp. 2N/AN/AN/AN/AN/A
ChargepointN/AN/AN/AN/AN/A

Summary

Chargepoint beats Altimeter Growth Corp. 2 on 2 of the 2 factors compared between the two stocks.

Altimeter Growth Corp. 2 (NYSE:AGCB) and CM Life Sciences (NASDAQ:CMLF) are both small-cap unclassified companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk.

Analyst Ratings

This is a breakdown of current ratings and target prices for Altimeter Growth Corp. 2 and CM Life Sciences, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Altimeter Growth Corp. 20000N/A
CM Life Sciences0000N/A

Earnings and Valuation

This table compares Altimeter Growth Corp. 2 and CM Life Sciences' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Altimeter Growth Corp. 2N/AN/AN/AN/AN/A
CM Life SciencesN/AN/AN/AN/AN/A

Profitability

This table compares Altimeter Growth Corp. 2 and CM Life Sciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Altimeter Growth Corp. 2N/AN/AN/A
CM Life SciencesN/AN/AN/A

Altimeter Growth Corp. 2 (NYSE:AGCB) and Ajax I (NYSE:AJAX) are both small-cap unclassified companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings and valuation.

Profitability

This table compares Altimeter Growth Corp. 2 and Ajax I's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Altimeter Growth Corp. 2N/AN/AN/A
Ajax IN/AN/AN/A

Valuation & Earnings

This table compares Altimeter Growth Corp. 2 and Ajax I's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Altimeter Growth Corp. 2N/AN/AN/AN/AN/A
Ajax IN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for Altimeter Growth Corp. 2 and Ajax I, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Altimeter Growth Corp. 20000N/A
Ajax I0000N/A

Ajax I (NYSE:AJAX) and Altimeter Growth Corp. 2 (NYSE:AGCB) are both small-cap unclassified companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Analyst Ratings

This is a breakdown of current recommendations for Ajax I and Altimeter Growth Corp. 2, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
Altimeter Growth Corp. 20000N/A

Valuation and Earnings

This table compares Ajax I and Altimeter Growth Corp. 2's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
Altimeter Growth Corp. 2N/AN/AN/AN/AN/A

Profitability

This table compares Ajax I and Altimeter Growth Corp. 2's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
Altimeter Growth Corp. 2N/AN/AN/A

Altimeter Growth Corp. 2 (NYSE:AGCB) and TPG Pace Beneficial Finance (NYSE:TPGY) are both small-cap unclassified companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, dividends, earnings, valuation, profitability, risk and institutional ownership.

Profitability

This table compares Altimeter Growth Corp. 2 and TPG Pace Beneficial Finance's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Altimeter Growth Corp. 2N/AN/AN/A
TPG Pace Beneficial FinanceN/AN/AN/A

Earnings & Valuation

This table compares Altimeter Growth Corp. 2 and TPG Pace Beneficial Finance's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Altimeter Growth Corp. 2N/AN/AN/AN/AN/A
TPG Pace Beneficial FinanceN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings for Altimeter Growth Corp. 2 and TPG Pace Beneficial Finance, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Altimeter Growth Corp. 20000N/A
TPG Pace Beneficial Finance0000N/A

Bridgetown (NASDAQ:BTWN) and Altimeter Growth Corp. 2 (NYSE:AGCB) are both small-cap unclassified companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability.

Profitability

This table compares Bridgetown and Altimeter Growth Corp. 2's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BridgetownN/AN/AN/A
Altimeter Growth Corp. 2N/AN/AN/A

Earnings and Valuation

This table compares Bridgetown and Altimeter Growth Corp. 2's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgetownN/AN/AN/AN/AN/A
Altimeter Growth Corp. 2N/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and recommmendations for Bridgetown and Altimeter Growth Corp. 2, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bridgetown0000N/A
Altimeter Growth Corp. 20000N/A


Altimeter Growth Corp. 2 Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHPT
Chargepoint
1.0$24.21-17.0%$1.11 billionN/A0.00Upcoming Earnings
Analyst Report
News Coverage
CMLF
CM Life Sciences
0.0$16.01-13.6%$1.01 billionN/A0.00Increase in Short Interest
AJAX
Ajax I
0.0$10.53-4.3%$989.10 millionN/A0.00Increase in Short Interest
Gap Up
AJAX
Ajax I
0.0$10.53-4.3%$989.10 millionN/A0.00Increase in Short Interest
Gap Up
TPGY
TPG Pace Beneficial Finance
0.0$17.72-20.0%$958.04 millionN/A0.00Increase in Short Interest
BTWN
Bridgetown
0.0$11.56-3.0%$885.79 millionN/A0.00
BOAC
Bluescape Opportunities Acquisition
0.0$10.10-2.1%$782.92 millionN/A0.00Decrease in Short Interest
HZON
Horizon Acquisition Co. II
0.0$10.81-4.8%$751.11 millionN/A0.00Decrease in Short Interest
News Coverage
ACIC
Atlas Crest Investment
0.0$10.77-4.2%$722.29 millionN/A0.00
LCY
Landcadia Holdings III
0.0$10.04-0.4%$643.75 millionN/A0.00
HAAC
Health Assurance Acquisition
0.0$10.81-3.6%$620.20 millionN/A0.00
CFII
CF Finance Acquisition Corp. II
0.0$9.04-5.9%$608.65 millionN/A0.00
BOWX
BowX Acquisition
0.0$10.05-0.2%$607.98 millionN/A0.00Decrease in Short Interest
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.23-2.9%$592.31 millionN/A0.00Increase in Short Interest
News Coverage
GHVI
Gores Holdings VI
0.0$13.22-12.4%$557.25 millionN/A0.00
CTAC
Cerberus Telecom Acquisition
0.0$10.15-2.2%$527.50 millionN/A0.00
SPNV
Supernova Partners Acquisition
0.0$10.27-1.8%$525.77 millionN/A0.00
MAAC
Montes Archimedes Acquisition
0.0$9.93-0.7%$525.72 millionN/A0.00Decrease in Short Interest
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.81-1.9%$512.13 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$10.00-1.0%$508.16 millionN/A0.00
NGAC
NextGen Acquisition
0.0$10.29-1.7%$490.31 millionN/A0.00Decrease in Short Interest
HOL
Holicity
0.0$13.25-2.3%$485.63 millionN/A0.00Increase in Short Interest
News Coverage
LUXA
Lux Health Tech Acquisition
0.0$10.71-0.9%$466.18 millionN/A0.00Increase in Short Interest
News Coverage
HIGA
H.I.G. Acquisition
0.0$9.94-1.0%$459.21 millionN/A0.00Increase in Short Interest
TSIA
TS Innovation Acquisitions
0.0$11.22-4.7%$440.63 millionN/A0.00Increase in Short Interest
NSTB
Northern Star Investment Corp. II
0.0$9.96-0.9%$439.69 millionN/A0.00
GFX
Golden Falcon Acquisition
0.0$9.92-0.8%$431.25 millionN/A0.00
FSRV
FinServ Acquisition
0.0$13.16-0.2%$420.96 millionN/A0.00Increase in Short Interest
News Coverage
Gap Up
PIAI
Prime Impact Acquisition I
0.0$9.95-0.5%$405.11 millionN/A0.00
MUDS
Mudrick Capital Acquisition Co. II
0.0$9.88-1.2%$395.31 millionN/A0.00
IGAC
IG Acquisition
0.0$9.91-1.1%$387.02 millionN/A0.00Decrease in Short Interest
INAQ
INSU Acquisition Corp. II
0.0$12.03-19.3%$358.89 millionN/A0.00High Trading Volume
HCAR
Healthcare Services Acquisition
0.0$9.84-1.1%$358.20 millionN/A0.00
VIH
VPC Impact Acquisition
0.3$12.64-9.3%$357.98 millionN/A0.00
CND
Concord Acquisition
0.0$9.94-0.1%$350.05 millionN/A0.00
ATAC
Altimar Acquisition
0.0$9.99-1.0%$346.84 millionN/A0.00
BTNB
Bridgetown 2
0.0$10.44-6.0%$339.30 millionN/A0.00Quiet Period Expiration
Gap Up
FTIV
Fintech Acquisition Corp. IV
1.7$10.12-2.8%$327.39 millionN/A0.00Decrease in Short Interest
News Coverage
DCRB
Decarbonization Plus Acquisition
0.0$10.97-3.8%$322.60 millionN/A0.00
ASPL
Aspirational Consumer Lifestyle
0.0$10.63-0.2%$317.96 millionN/A0.00
HPX
HPX
0.0$10.04-0.2%$316.88 millionN/A0.00
CRSA
Crescent Acquisition
0.0$10.10-0.0%$315.63 millionN/A0.00
BSN
Broadstone Acquisition
0.0$9.86-2.4%$308.35 millionN/A0.00Increase in Short Interest
GIK
GigCapital3
0.0$10.95-8.6%$307.87 millionN/A0.00Gap Up
ARBG
Aequi Acquisition
0.0$9.96-2.1%$292.39 millionN/A0.00
PIPP
Pine Island Acquisition
1.0$10.04-3.1%$285.55 millionN/A0.00
CCAC
CITIC Capital Acquisition
0.3$10.14-1.2%$283.18 millionN/A0.00Increase in Short Interest
News Coverage
MTAC
MedTech Acquisition
0.0$10.01-1.0%$272.53 millionN/A0.00
IACA
ION Acquisition Corp 1
0.0$10.61-1.1%$271.43 millionN/A0.00Decrease in Short Interest
News Coverage
ACAC
Acies Acquisition
0.0$10.01-0.4%$268.25 millionN/A0.00Increase in Short Interest
News Coverage
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.